Tokyo, March 31, 2017 – Rakuten, Inc. today announced that its wholly-owned subsidiaries Kenko.com, Inc. and Soukai Drug Co., Ltd. will be merged on July 1, 2017. Following this merger, Noriaki Komori will assume on the role of Representative Director & CEO at the new company.
Both companies are e-commerce businesses selling daily necessities, and both have stores on Rakuten’s internet shopping mall, Rakuten Ichiba. The merger will unify the two companies, which have highly similar business structures, to enable more efficient operations and further enhance the Rakuten Ichiba customer experience.
Rakuten Group will continue to streamline management resources and strengthen operation fundamentals in order to provide the best possible service to users.
Summary of merger
(1) Schedule
Merger resolution at the shareholders’ meeting: Kenko.com, Inc.: March 31, 2017
Soukai Drug Co., Ltd.: March 27, 2017
Date of merger: July 1, 2017 (scheduled)
(2) Merger method
Kenko.com will be the surviving company under absorption-type merger, and Soukai Drug Co., Ltd. will be absorbed.
Overview of companies in merger
|
Company name |
Kenko.com, Inc. |
Soukai Drug Co., Ltd. |
|
Address |
1-15-6 Tenjin Chuo-ku, Fukuoka-shi Fukuoka |
Kojimachimitsuba Bldg. 1F 3-5 Niban-cho, Chiyoda-ku Tokyo |
|
Name, title of representative |
Shunsuke Yazawa, Representative Director & CEO |
Noriaki Komori, Representative Director & CEO |
|
Main business |
E-commerce, handling daily necessities with a focus on health-related products |
E-commerce, handling a wide range of products with a focus on daily necessities |
|
Date of establishment |
November 8, 1994 |
August 11, 2000 |
|
Main shareholders |
Rakuten, Inc. 100% |
Rakuten, Inc. 100% |
Post-merger details (following scheduled date of July 1, 2017)
|
Company name |
To be determined |
|
Address |
To be determined |
|
Name, title of representative |
Noriaki Komori, Representative Director & CEO |
|
Main business |
Services relating to the sale of daily necessities through e-commerce |